Adicet Bio, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Adicet Bio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $6.00K, a 500.00% increase year-over-year.
- Adicet Bio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $189.00K, a 6200.00% increase year-over-year.
- Adicet Bio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $1.00K, a 99.45% decline year-over-year.
- Adicet Bio, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $3.00K, a 96.77% decline year-over-year.
- Adicet Bio, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $1.00K, a 99.49% decline from fiscal 2024.
- Adicet Bio, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $195.00K, a 4775.00% increase from fiscal 2023.
- Adicet Bio, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $4.00K, a 99.70% decline from fiscal 2022.
- Adicet Bio, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $1.31M, a 71.95% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $1.00K 10-K · filed 2026-03-12 | |
| 2024-12-31 | $195.00K 10-K · filed 2026-03-12 | |
| 2024-06-30 | $6.00K 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $189.00K 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $4.00K 10-K · filed 2025-03-06 | |
| 2023-06-30 | $1.00K 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $3.00K 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $1.31M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $191.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $183.00K 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $93.00K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $4.69M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $367.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $279.00K 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $976.00K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $460.00K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $144.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $7.00K 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $42.00K 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $30.00K 10-K · filed 2021-03-12 | |
| 2019-09-30 | $8.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $7.00K 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $9.00K 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $221.00K 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |